StockData
CorMedix Inc. logo

CorMedix Inc. (CRMD) stock

CRMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/30
$4.67−0.15 (-3.11%)

Close on Nov 17, 2026Market cap $364.00MP/E –Yield –

CorMedix operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

CorMedix's operating cash flow for the twelve months ending Jun 30, 2026 was $253.94M, up 733.6% year over year. For fiscal 2025 it was $175.05M. The highest annual figure on record is $175.05M in fiscal 2025.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$175.05M–
FY2024Dec 31, 2024-$50.62M–
FY2023Dec 31, 2023-$38.41M–
FY2022Dec 31, 2022-$24.36M–
FY2021Dec 31, 2021-$21.16M–
FY2020Dec 31, 2020-$21.97M–
FY2019Dec 31, 2019-$15.05M–
FY2018Dec 31, 2018-$23.70M–
FY2017Dec 31, 2017-$28.59M–
FY2016Dec 31, 2016-$22.27M–
FY2015Dec 31, 2015-$12.53M–
FY2014Dec 31, 2014-$6.32M–
FY2013Dec 31, 2013-$3.62M–
FY2012Dec 31, 2012-$2.28M–
FY2011Dec 31, 2011-$6.30M–
FY2010Dec 31, 2010-$3.67M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$86.24M+187.5%
Q1 FY2026Mar 31, 2026$42.38M+114.7%
Q4 FY2025Dec 31, 2025$94.46M–
Q3 FY2025Sep 30, 2025$30.86M–
Q2 FY2025Jun 30, 2025$29.99M–
Q1 FY2025Mar 31, 2025$19.74M–
Q4 FY2024Dec 31, 2024-$5.61M–
Q3 FY2024Sep 30, 2024-$13.65M–
Q2 FY2024Jun 30, 2024-$14.04M–
Q1 FY2024Mar 31, 2024-$17.31M–
Q4 FY2023Dec 31, 2023-$10.75M–
Q3 FY2023Sep 30, 2023-$8.70M–
Q2 FY2023Jun 30, 2023-$8.57M–
Q1 FY2023Mar 31, 2023-$10.39M–
Q4 FY2022Dec 31, 2022-$6.15M–
Q3 FY2022Sep 30, 2022-$6.00M–
Q2 FY2022Jun 30, 2022-$5.46M–
Q1 FY2022Mar 31, 2022-$6.74M–
Q4 FY2021Dec 31, 2021-$5.87M–
Q3 FY2021Sep 30, 2021-$5.50M–
Q2 FY2021Jun 30, 2021-$3.09M–
Q1 FY2021Mar 31, 2021-$6.69M–
Q4 FY2020Dec 31, 2020-$5.93M–
Q3 FY2020Sep 30, 2020-$7.31M–
Q2 FY2020Jun 30, 2020-$754.37K-558.7%
Q1 FY2020Mar 31, 2020-$7.97M–
Q4 FY2019Dec 31, 2019-$3.88M–
Q3 FY2019Sep 30, 2019-$3.96M–
Q2 FY2019Jun 30, 2019$164.46K–
Q1 FY2019Mar 31, 2019-$7.37M–
Q4 FY2018Dec 31, 2018-$7.20M–
Q3 FY2018Sep 30, 2018-$5.11M–
Q2 FY2018Jun 30, 2018-$4.34M–
Q1 FY2018Mar 31, 2018-$7.05M–
Q4 FY2017Dec 31, 2017-$7.28M–
Q3 FY2017Sep 30, 2017-$6.80M–
Q2 FY2017Jun 30, 2017-$7.75M–
Q1 FY2017Mar 31, 2017-$6.76M–
Q4 FY2016Dec 31, 2016-$6.50M–
Q3 FY2016Sep 30, 2016-$6.55M–

More CorMedix figures

See a number that looks wrong?